Methods One hundred and seventy-eight patients with breast cancer underwent PET/CT together with bone scan within 1 month between July and November 2011 for restaging and initial staging were included ...

The case studies were chosen using the criteria that both PET/CT and bone scintigraphy studies were performed, scans were performed in less than 1 year of one another, patients had a metastatic cancer ...

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

a diagnosis of ‘super bone scan’ was made (figure 1). Prostate biopsy revealed adenocarcinoma. The diagnosis was bone metastases from prostate cancer. Antiandrogens and GnRH antagonists were ...

In the 2024 JAMA Network Open study, 2 upfront or reflex PSMA-PET was estimated to diagnose more patients with metastasis compared with conventional bone scan alone: 611 and 630 vs 297.

Prostate-specific membrane antigen (PSMA)-PET/CT has shown considerable promise in the evaluation of prostate cancer bone metastases; however, data utilizing a histopathologic reference standard in ...

A restaging CT scan revealed progressive disease in the pelvis and abdomen. She was treated with palliative radiotherapy, dexamethasone, and opoid analgesia, and a good response was seen. Further ...

The objective of this work presented by Dr. Sayyid and colleagues was to determine the prevalence and clinical predictors of mesorectal lymph node metastases in prostate cancer patients undergoing a ...

“Our study demonstrates the critical role of PSMA-PET in accurately staging prostate cancer, which can significantly impact treatment decisions and outcomes,” said Jeremie Calais, MD, PhD.